Seed funding round for Thymmune Therapeutics raising $7M in February 2023
Seed funding round for Thymmune Therapeutics raising $7M in February 2023
| Investor | Firm Type | Partner |
|---|
Pillar VCLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Judy Pagliuca | |
| Angel | John Maraganore | |
| Angel | George M. Church | |
| Angel | Mark Bamforth OBE | |
| Angel | James Fordyce | |
| Angel | Philip Reilly |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$44M
Top Valuation
-
Thymmune Therapeutics raised $7M in a Seed round.
The round was announced on 02/01/23.
The round was led by Thomas de Vlaam.